TVTX FY 2012 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$30M

Net Income

-$30M

EPS (Diluted)

$-284.40

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$2M

Total Liabilities

$6M

Stockholders' Equity

-$3M

Cash & Equivalents

$11,388

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$30M	-$12,825	-235651.9%
Net Income	-$30M	-$14,825	-204580.3%